Abstract:Heart valve disease affects up to 30% of the population and has been shown to have origins during embryonic development. Valvulogenesis begins with formation of endocardial cushions in the atrioventricular canal and outflow tract regions. Subsequently, endocardial cushions remodel, elongate and progressively form mature valve structures composed of a highly organized connective tissue that provides the necessary biomechanical function throughout life. While endocardial cushion formation has been well studied, the processes required for valve remodeling are less well understood. The transcription factor Scleraxis (Scx) is detected in mouse valves from E15.5 during initial stages of remodeling, and expression remains high until birth when formation of the highly organized mature structure is complete. Heart valves from Scx-/- mice are abnormally thick and develop fibrotic phenotypes similar to human disease by juvenile stages. These phenotypes begin around E15.5 and are associated with defects in connective tissue organization and valve interstitial cell differentiation. In order to understand the etiology of this phenotype, we analyzed the transcriptome of remodeling valves isolated from E15.5 Scx-/- embryos using RNA-seq. From this, we have identified a profile of protein and non-protein mRNAs that are dependent on Scx function and using bioinformatics we can predict the molecular functions and biological processes affected by these genes. These include processes and functions associated with gene regulation (methyltransferase activity, DNA binding, Notch signaling), vitamin A metabolism (retinoic acid biosynthesis) and cellular development (cell morphology, cell assembly and organization). In addition, several mRNAs are affected by alternative splicing events in the absence of Scx, suggesting additional roles in post-transcriptional modification. In summary, our findings have identified transcriptome profiles from abnormal heart valves isolated from E15.5 Scx-/- embryos that could be used in the future to understand mechanisms of heart valve disease in the human population.

Development of heart valve leaflets and supporting apparatus in chicken and mouse embryos

Maturation of heart valve cell populations during postnatal remodeling

Murine aortic valve cell heterogeneity at birth

RNA-Seq Analysis to Identify Novel Roles of Scleraxis during Embryonic Mouse Heart Valve Remodeling

Hemodynamics in Cardiac Development

Differential Development of the Chordae Tendineae and Anterior Leaflet of the Bovine Mitral Valve

Understanding the cell fate and behavior of progenitors at the origin of the mouse cardiac mitral valve

Genomic Analysis Distinguishes Phases of Early Development of the Mouse Atrio-Ventricular Canal

Co-ordinating Notch, BMP, and TGF-β Signaling During Heart Valve Development.

Non-pathological Chondrogenic Features of Valve Interstitial Cells in Normal Adult Zebrafish

Developmental anatomy of the heart: a tale of mice and man

Twist1 Transcriptional Targets in the Developing Atrio-Ventricular Canal of the Mouse

A Notch‐dependent Transcriptional Hierarchy Promotes Mesenchymal Transdifferentiation in the Cardiac Cushion

Valvulogenesis: the moving target

Single-cell transcriptomic analysis identifies murine heart molecular features at embryonic and neonatal stages

Developmental Mechanisms Of Aortic Valve Malformation And Disease

Wnt signaling in heart valve development and osteogenic gene induction

Sox9 is required for precursor cell expansion and extracellular matrix organization during mouse heart valve development

Notch-Tnf Signalling is Required for Development and Homeostasis of Arterial Valves

Scleraxis Is Required for Cell Lineage Differentiation and Extracellular Matrix Remodeling During Murine Heart Valve Formation In Vivo